LT-Mac Cream contains Luliconazole 1% w/w, a potent antifungal agent belonging to the imidazole class, indicated for the topical treatment of superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. LT-Mac Cream is primarily used in the management of conditions such as tinea corporis, tinea cruris, and tinea pedis. The cream should be applied once daily to the affected area and surrounding skin after cleaning and drying, typically for a duration of 2 to 4 weeks depending on the severity and clinical response. Adverse effects are generally mild and may include local irritation, burning sensation, erythema, or pruritus at the application site. LT-Mac Cream is contraindicated in patients with known hypersensitivity to luliconazole or any excipients in the formulation. It is intended for external use only and should be kept away from eyes and mucous membranes. Patients are advised to complete the full course of therapy to prevent recurrence and resistance. Consultation with a healthcare professional is recommended before use, especially in pregnant or breastfeeding women.